Search results for "asma"

showing 10 items of 4204 documents

Limited antibody specificity compromises epitranscriptomic analyses

2019

International audience; A controversial discussion on the occurrence of the RNA modification m1A in mRNA takes a new turn, as an antibody with a central role in modification mapping was shown to also bind mRNA cap structures.

0301 basic medicineScienceGeneral Physics and Astronomy02 engineering and technologyPlasma protein bindingAntibodiesGeneral Biochemistry Genetics and Molecular BiologyEpigenesis GeneticTranscriptome03 medical and health sciencesAntibody Specificity[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]AnimalsHumansRNA Messengerlcsh:ScienceEpigenesisRegulation of gene expressionMessenger RNAMultidisciplinarybiologyCommentQRNA[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologyGeneral ChemistryDNA MethylationRNA modification021001 nanoscience & nanotechnologyCell biology030104 developmental biologyGene Expression RegulationDNA methylationbiology.proteinRNAlcsh:QAntibodyTranscriptome0210 nano-technologyProtein Binding
researchProduct

Human platelet-rich plasma improves the nesting and differentiation of human chondrocytes cultured in stabilized porous chitosan scaffolds

2017

[EN] The clinical management of large-size cartilage lesions is difficult due to the limited regenerative ability of the cartilage. Different biomaterials have been used to develop tissue engineering substitutes for cartilage repair, including chitosan alone or in combination with growth factors to improve its chondrogenic properties. The main objective of this investigation was to evaluate the benefits of combining activated platelet-rich plasma with a stabilized porous chitosan scaffold for cartilage regeneration. To achieve this purpose, stabilized porous chitosan scaffolds were prepared using freeze gelation and combined with activated platelet-rich plasma. Human primary articular chond…

0301 basic medicineShort CommunicationsBiomedical EngineeringMedicine (miscellaneous)Human plateletCartilage tissue engineeringBiomaterialsChitosanlcsh:Biochemistry03 medical and health scienceschemistry.chemical_compoundTissue engineeringActivated platelet-rich plasmamedicinelcsh:QD415-436Cartilage repairPorosityCartilageRegeneration (biology)Stabilized porous chitosantechnology industry and agricultureAnatomyChondrogenesisequipment and supplies030104 developmental biologymedicine.anatomical_structurechemistryMAQUINAS Y MOTORES TERMICOSTERMODINAMICA APLICADA (UPV)Biomedical engineering
researchProduct

Toxoplasma gondii detection and viability assays in ham legs and shoulders from experimentally infected pigs

2015

Abstract Epidemiological studies of toxoplasmosis show that infection in humans is mainly caused by the consumption of raw, undercooked or cured meat. Cured “Serrano” ham is a typical pork product from the Mediterranean area, highly valued for its flavour. The “Serrano” ham is prepared from pork meat and undergoes a process known as curing and a subsequent fermentation without thermal or smoking treatments. The viability of Toxoplasma gondii in hams and shoulders from experimentally infected pigs that have been subject to different curing processes has been studied in order to evaluate the best method to completely eliminate the viable protozoa. The different treatments include, i) freezing…

0301 basic medicineShoulderCuring (food preservation)Water activitySwineShoulders030106 microbiologyMicrobiologyMice03 medical and health sciencesChlorocebus aethiopsparasitic diseasesAnimalsHumansBioassayFood scienceVero CellsInfectivityLegbiologyChemistrySaltingToxoplasma gondiibiology.organism_classificationMeat ProductsDisease Models AnimalRed Meat030104 developmental biologyFood MicrobiologyFemaleFermentationToxoplasmaFrozen FoodsToxoplasmosisFood ScienceFood Microbiology
researchProduct

Evaluation of the Possibility to Detect Circulating Tumor DNA From Pituitary Adenoma

2019

Objective: Circulating free DNA (cfDNA) in general and circulating tumor DNA (ctDNA) in particular is becoming an increasingly used form of liquid biopsy biomarkers. In this study, we are investigating the ability to detect ctDNA from the plasma of pituitary adenoma (PA) patients. Design: Tumor tissue samples were obtained from planed PA resections, before which blood plasma samples were taken. Somatic variants found in PA tissue samples were evaluated in related cfDNA, isolated from plasma samples. Methods: Sanger sequencing, as well as previously obtained whole-exome sequencing data, were used to evaluate somatic variants composition in tumor tissue samples. cfDNA was isolated from the sa…

0301 basic medicineSomatic cellEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismpituitary adenomaBiologylcsh:Diseases of the endocrine glands. Clinical endocrinologyDNA sequencing03 medical and health sciencessymbols.namesakeGNAS0302 clinical medicineEndocrinologyBlood plasmaTaqManGNAS complex locusLiquid biopsyOriginal ResearchSanger sequencingcirculating tumor DNAlcsh:RC648-665AmpliconMolecular biology030104 developmental biologybiology.proteinsymbolsnext-generation sequencingcompetitive allele-specific TaqManFrontiers in Endocrinology
researchProduct

Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses

2015

Rhodamine 123 (R123) transport substrate sensitizes P-glycoprotein (P-gp) to inhibition by compound 2c (cis-cis) N,N-bis(cyclohexanolamine)aryl ester isomer in a concentration-dependent manner in human MDR1-gene transfected mouse T-lymphoma L5178 cells as shown previously. By contrast, epirubicin (EPI) concentration changes left unaltered 2c IC50 values of EPI efflux. To clarify this discrepancy, defined molecular docking (DMD) analyses of 12 N,N-bis(cyclohexanolamine)aryl esters, the highly flexible aryl ester analog 4, and several P-gp substrate/non-substrate inhibitors were performed on human P-gp drug- or nucleotide-binding domains (DBD or NBD). DMD measurements yielded lowest binding e…

0301 basic medicineStereochemistryCell Culture TechniquesCancer drug resistance; Molecular docking; NN-Bis(cyclohexanolamine)aryl ester; P-glycoproteinPlasma protein bindingP-glycoproteinTransfectionBiochemistryRhodamine 123Substrate Specificity03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineCell Line TumorAnimalsRhodamine 123ATP Binding Cassette Transporter Subfamily B Member 1Binding siteP-glycoproteinEpirubicinPharmacologyBinding SitesbiologyMolecular StructureArylEstersCancer drug resistanceNCyclohexanolsMolecular Docking SimulationProtein Transport030104 developmental biologychemistryDocking (molecular)030220 oncology & carcinogenesisMolecular dockingbiology.proteinN-Bis(cyclohexanolamine)aryl esterEffluxBinding domainProtein Binding
researchProduct

Circadian Rhythm Variations and Nutrition in Children

2018

AbstractCircadian rhythms are the changes in biological processes that occur on a daily basis. Among these processes are reactions involved in metabolic homeostasis. Circadian rhythms are structured by the central clock in the suprachiasmatic nucleus of the hypothalamus via the control of melatonin expression. Circadian rhythms are also controlled by the peripheral clocks, which are intracellular mechanisms composed of the clock genes, whose expression follows a circadian pattern. Circadian rhythms are impacted by signals from the environment called zeitgebers, or time givers, which include light exposure, feeding schedule and composition, sleeping schedule and pattern, temperature, and phy…

0301 basic medicineSuprachiasmatic nucleusMetabolic homeostasisBiologyMelatoninCLOCK03 medical and health sciences030104 developmental biology0302 clinical medicineHypothalamusPediatrics Perinatology and Child HealthZeitgebermedicineSurgeryCircadian rhythmNeuroscience030217 neurology & neurosurgerymedicine.drugLight exposureJournal of Child Science
researchProduct

IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively

2016

International audience; Interferon regulatory factor-8 (IRF8) has been proposed to be essential for development of monocytes, plasmacytoid dendritic cells (pDCs) and type 1 conventional dendritic cells (cDC1s) and remains highly expressed in differentiated DCs. Transcription factors that are required to maintain the identity of terminally differentiated cells are designated `' terminal selectors.'' Using BM chimeras, conditional Irf8(fl/fl) mice and various promotors to target Cre recombinase to different stages of monocyte and DC development, we have identified IRF8 as a terminal selector of the cDC1 lineage controlling survival. In monocytes, IRF8 was necessary during early but not late d…

0301 basic medicineT-LymphocytesCellular differentiationImmunologyCre recombinasePlasmacytoid dendritic cellBiologyMonocytesMice03 medical and health sciences0302 clinical medicineInterferonmedicineAnimalsImmunology and AllergyPromoter Regions GeneticMonocyteCell DifferentiationDendritic CellsDendritic cellCell biologyMice Inbred C57BL030104 developmental biologyInfectious Diseasesmedicine.anatomical_structureInterferon Regulatory FactorsInterferon Type ICancer research[SDV.IMM]Life Sciences [q-bio]/ImmunologyIRF8Transcription Factors030215 immunologyIRF4medicine.drugImmunity
researchProduct

Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells.

2016

// Elena Lo Presti 1,2 , Nadia Caccamo 1,2 , Valentina Orlando 1,2 , Francesco Dieli 1,2 and Serena Meraviglia 1,2 1 Central Laboratory of Advanced Diagnosis and Biomedical Research (CLADIBIOR), University of Palermo, Palermo, Italy 2 Department of Biopathology and Medical Biotechnologies (DIBIMED), University of Palermo, Palermo, Italy Correspondence to: Serena Meraviglia, email: // Keywords : γδ T cells, plasmacytoid dendritic cells, IL-17, TLR activation, proliferation, Immunology and Microbiology Section, Immune response, Immunity Received : July 20, 2016 Accepted : August 02, 2016 Published :August 31, 2016 Abstract Vγ9Vδ2 T cells and plasmacytoid dendritic cells (pDCs) are two distinc…

0301 basic medicineTLR activationCellCell CommunicationLigandsLymphocyte Activation0302 clinical medicineT-Lymphocyte SubsetsCoculture TechniqueAntigen PresentationInterleukin-17Research Paper: Immunologyhemic and immune systemsIL-17medicine.anatomical_structurePhenotypeOncologyplasmacytoid dendritic cellsImmunology and Microbiology SectionInterleukin 17HumanCell typeproliferationCD40 LigandLigandBiologyDendritic Cellγδ T cells03 medical and health sciencesInducible T-Cell Co-Stimulator LigandInterferon-gammaImmune systemImmunityplasmacytoid dendritic cellmedicineHumansImmune responseCell Proliferationγδ T cellCD40Innate immune systemImmunityTLR9Dendritic CellsReceptors OX40Coculture TechniquesImmunity Innate030104 developmental biologyImmunologybiology.proteinLeukocytes MononuclearCpG IslandsCpG IslandImmunologic Memory030215 immunologyOncotarget
researchProduct

Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma

2018

Aim: A simple, rapid, economical and sensitive HPLC-UV method was developed for the simultaneous quantification of ceftolozane and tazobactam in plasma samples. Methodology: After deproteinization followed by a liquid–liquid back-extraction, the compounds were separated on a C18 column (150 mm × 4.6 mm, 5 μm) with UV-visible detection at 220 nm. The mobile phase consisted of acetonitrile and potassium dihydrogenphosphate buffer at pH 3.0 (8:92, v/v), delivered isocratically at a flow rate of 1.0 ml/min and at a column oven temperature of 30°C. Cefepime was used as an internal standard. Results: Linearity was achieved in the concentration range of 0.50–100.00 μg/ml for ceftolozane and 0.25–…

0301 basic medicineTazobactam030106 microbiologyClinical BiochemistryPenicillanic Acid01 natural sciencesHigh-performance liquid chromatographyTazobactamAnalytical ChemistryPlasma03 medical and health sciencesmedicineHumansSample preparationGeneral Pharmacology Toxicology and PharmaceuticsChromatography High Pressure LiquidReproducibilityChromatographyPlasma samplesmedicine.diagnostic_testChemistry010401 analytical chemistryGeneral MedicineAnti-Bacterial AgentsCephalosporins0104 chemical sciencesMedical Laboratory TechnologyTherapeutic drug monitoringHuman plasmaCeftolozanemedicine.drugBioanalysis
researchProduct

Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018

2018

OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one m…

0301 basic medicineTechnologymedicine.medical_specialtymedication-related osteonecrosis of the jawsplatelet-rich fibrin610 Medicine & healthOdontologi03 medical and health sciencesEngineering0302 clinical medicinesystematic reviewguided bone regeneration sinus floor elevationdental implantsDentistry Oral Surgery & Medicinemedicineantiresorptive drugstitanium610 Medicine & healthEngineering BiomedicalbisphosphonatesScience & Technologycorrosionbusiness.industryConsensus conferenceimplant therapyplatelet-rich plasma030206 dentistryddc:617.63. Good healthhormone replacement therapyAntiresorptive Drugs030104 developmental biologySystematic reviewGroup analysisDentistryFamily medicinealveolar ridge preservationOral SurgerybusinessLife Sciences & Biomedicineperi-implantitisClinical Oral Implants Research
researchProduct